AACC Guidance Document on the Use of Point-of-Care Testing in Fertility and Reproduction . (1st September 2022)

• Record Type: Journal Article
• Authors: Nichols, James H; Ali, Mahesheema; Anetor, John I; Chen, Li Sheng; Chen, Yu; Collins, Sean; Das, Saswati; Devaraj, Sridevi; Fu, Lei; Karon, Brad S; Kary, Heba; Nerenz, Robert D; Rai, Alex J; Shajani-Yi, Zahra; Thakur, Vinita; Wang, Sihe; Yu, Hoi Ying Elsie; Zamora, Lindsey E
• Is Part Of: Journal of applied laboratory medicine. Volume 7:Number 5(2022)
• Page Start: 1202
• Page End: 1236
• Publication Date: 2022-09-01
• Subjects: Clinical chemistry -- Periodicals; Diagnosis, Laboratory -- Periodicals; 616.0756
• DOI: 10.1093/jalm/jfac042
• Languages: English
• ISSNs: 2576-9456

Abstract

Abstract: Background: The AACC Academy revised the reproductive testing section of the Laboratory Medicine Practice Guidelines: Evidence-Based Practice for Point-of-Care Testing (POCT) published in 2007. Methods: A panel of Academy members with expertise in POCT and laboratory medicine was formed to develop guidance for the use of POCT in reproductive health, specifically ovulation, pregnancy, premature rupture of membranes (PROM), and high-risk deliveries. The committee was supplemented with clinicians having Emergency Medicine and Obstetrics/Gynecology training. Results: Key recommendations include the following. First, urine luteinizing hormone (LH) tests are accurate and reliable predictors of ovulation. Studies have shown that the use of ovulation predicting kits may improve the likelihood of conception among healthy fertile women seeking pregnancy. Urinary LH point-of-care testing demonstrates a comparable performance among other ovulation monitoring methods for timing intrauterine insemination and confirming sufficient ovulation induction before oocyte retrieval during in vitro fertilization. Second, pregnancy POCT should be considered in clinical situations where rapid diagnosis of pregnancy is needed for treatment decisions, and laboratory analysis cannot meet the required turnaround time. Third, PROM testing using commercial kits alone is not recommended without clinical signs of rupture of membranes, such as leakage of amniotic fluid from the cervical opening. Finally, fetal scalp lactate is used more than fetal scalp pH for fetal acidosis due to higher success rate and low volume of sample required. Conclusions: This revision of the AACC Academy POCT guidelines provides recommendations for best practice use of POCT in fertility and reproduction.